27 March 2023 in Systemic Hypertension
Background. The population of patients undergoing large joints arthroplasty has a high prevalence of comorbidities, such as hypertension and other cardiovascular diseases, obesity, diabetes, chronic kidney disease, etc., that are independent risk factors for the postoperative complications, especially of the thromboembolic events.Aim. To evaluate the prevalence of hypertension and other risk factors in patients undergoing large joint arthroplasty in real-world practice.Materials and methods. The study included an unselected sample of patients (n=82) who underwent arthroplasty of large joints in December 2022 at the Clinic of Traumatology, Orthopedics and Joint Pathology of the I.M. Sechenov First Moscow State Medical University. A detailed history was collected from all patients and, if necessary, a laboratory and instrumental examination was performed to assess the presence of target organ damage.Results. Sixty-two patients (81.7%) had hypertension; among them 12.6% had no previous antihypertensive therapy. The average body mass index (BMI) was 31.3±5.2 kg/m2 confirming the high prevalence of obesity in this population. All obese patients had concomitant hypertension (n=62), and 6 people (7.3%) with a BMI over 40 kg/m2 had signs of obstructive sleep apnea syndrome. Diabetes mellitus (DM) was diagnosed in 13 people (15.9%); in all cases it was type 2 diabetes. Chronic kidney disease (CKD) stage 2-4 was diagnosed in 67 people (81.7%), and all these patients had concomitant obesity and hypertension.Conclusion. Based on the analysis of published literature and a sample of patients from real-world practice, the main population undergoing the arthroplasty of large joints include elder patients, and the vast majority of them have multiply comorbidities (obesity, hypertension, CKD) that are not only the independent risk factors for poor prognosis, but also exacerbate the other concomitant conditions and further increase the risk of complications. It is necessary to conduct large prospective studies with specific evaluation of various cohorts of patients undergoing arthroplasty of large joints including a pharmacoeconomic analysis to determine the need and scope of further examination in this population with a high risk of perioperative complications.
13 April 2025 in Siberian Journal of Clinical and Experimental Medicine
Background. The condition of patients after orthopedic surgery requires therapeutic monitoring with correction of concomitant therapy.Aim: To study changes of the general condition of patients after elective total knee arthroplasty (TKA) and elective total hip arthroplasty (THA) over time through active therapeutic monitoring to optimize management.Materials and Methods. This prospective cohort single-center study included 782 patients with detailed medical history, information about concomitant diseases and drug therapy. The severity of pain was assessed on a 10-point scale before surgery and then 1 and 3 months after arthroplasty.Results. The study population included 271 males (34.7%) and 511 females (65.3%). 595 subjects (76.1%) had hypertension (grade 1 – 71 patients, grade 2 – 252 patients, grade 3 – 272 patients). At 1 month after surgery, 18 patients (2.3%) reported instable blood pressure (BP), 43 patients (5.5%) reported a persistent BP decrease requiring a reduction of antihypertensive drugs doses. Before surgery 604 patients (77.2%) were taking non-steroidal anti-inflammatory drugs (NSAIDs); at 1 month a significant (p < 0.0001) decrease in the frequency of NSAIDs was noted – only 332 patients (42.4%) continued taking NSAIDs. At 1, 3 and 6 months after surgery, 17, 27 and 44 patients, respectively, reported an increase of pain severity in the joints of the intact extremity with an increase in the need for NSAIDs; about half of this subgroup also reported an increase in the number of episodes of elevated BP. Correlation analysis after surgery revealed a significant relationship between BP and the pain severity (r = 0.731, p < 0.0001) and the frequency of taking NSAIDs (r = 0.681, p = 0.01), as well as the patient’s activity and the severity of pain in the non-operated extremity (r = 0.782, p < 0.0001).Conclusion. Patients undergoing elective TKA or THA have a high incidence of hypertension and often take NSAIDs. In the postoperative period, a statistically significant relationship between the severity of pain and NSAIDs use with BP levels, as well as a statistically significant relationship between activity and exacerbation of osteoarthritis of the joints of the non-operated extremity was found. This trend requires continued therapeutic monitoring in the postoperative period from 3 to 6 months for appropriate therapy correction.
31 July 2025 in Terapevticheskii arkhiv
Aim. To evaluate the safety and effectiveness of various antithrombotic prophylaxis regimens after elective total knee arthroplasty (TKA) and elective total hip arthroplasty (THA). Materials and methods. Medical history, information about concomitant diseases and previously prescribed drug therapy was recorded in all participants. Subsequently, a prospective observation was performed to record specific antithrombotic drugs and the duration of their use after surgery, patient compliance with the rehabilitation regimen, all cases of thrombosis and bleeding; all patients were contacted by phone 1 and 3 months after surgery. Results. The study population included 271 males (34.7%) and 511 females (65.3%). 332 (42.5%) patients underwent THA and 450 (57.5%) patients underwent TKA. In the perioperative period, 769 patients (98.3%) received fraxiparine monotherapy as antithrombotic prophylaxis, and 13 (1.7%) patients received fraxiparine in combination with an antiplatelet agent due to previous percutaneous coronary intervention or very high cardiac risk. Within 1 month after surgery, 31 (4.0%) patients did not take any anticoagulants despite the prescriptions, 20 (2.6%) patients used aspirin instead of the prescribed anticoagulants. Other patients received direct oral anticoagulants (dabigatran, rivaroxaban, or apixaban) or warfarin as prescribed; among them 73 (9.3%) patients received concomitant antiplatelet agents. Seven (0.9%) patients used three anticoagulants concomitantly. During the first month after surgery, 9 cases (1.2%) of deep vein thrombosis were recorded (5 patients took no anticoagulants, another 4 participants were not compliant with the rehabilitation regimen). 5 (0.6%) cases of epistaxis, 4 (0.5%) cases of hemorrhoidal bleeding and 2 (0.2%) cases of hematoma in the surgical area were reported. All cases of thrombosis and bleeding were mild and resolved spontaneously. No statistically significant differences in the incidence of adverse events were found between different anticoagulant therapy regimens. Conclusion. In a cohort of real-world patients undergoing elective TKA or THA, the differences between the effectiveness and safety of various anticoagulant prophylaxis regimens were not statistically significant. The incidence of thrombosis was low, and these complications were mainly reported in non-compliant patients. The incidence of bleeding in patients taking anticoagulants with antiplatelet agents was not elevated, however, the size of this subpopulation is small and does not allow to perform a significant assessment of the safety of this treatment regimen. Based on the findings, it is reasonable to develop additional methods to improve patient compliance in order to reduce the frequency of medication errors and decrease the incidence of possible complications.